Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medpace Holdings (MEDP)
NASDAQ:MEDP
Holding MEDP?
Track your performance easily
MEDP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$253.49 - $459.77
Previous Close$314.22
Volume338.97K
Average Volume (3M)342.81K
Market Cap
$9.89B
Enterprise Value$9.24B
Total Cash (Recent Filing)$656.90M
Total Debt (Recent Filing)$128.28M
Price to Earnings (P/E)27.5
Beta1.37
Next Earnings
Feb 17, 2025EPS Estimate
$2.94Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)11.42
Shares Outstanding31,081,601
10 Day Avg. Volume491,818
30 Day Avg. Volume342,810
Standard Deviation0.12
R-Squared0.34
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)11.08
Price to Sales (P/S)4.78
Price to Cash Flow (P/CF)16.60
P/FCF Ratio17.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.46
Enterprise Value/Gross Profit17.61
Enterprise Value/Ebitda19.30
Forecast
1Y Price Target
$361.17Price Target Upside14.94% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Medpace Holdings News
Bulls Say, Bears Say
Bulls Say
Cash Flow And ProfitabilityFree cash flow was strong, surpassing consensus estimates by a significant margin, indicating robust cash generation.
Financial PerformanceMEDP's earnings per share and EBITDA significantly exceeded analyst expectations, driven by better-than-expected cost management.
Market PerformanceMEDP stock is still one of the top performing stocks year-to-date (+17%) vs CRO peers CRL, FTRE, ICLR, and IQV down (3%) on average.
Bears Say
Bookings PerformanceThe sequential decline in the book-to-bill ratio and a year-over-year decline in bookings are worse than investor expectations.
Industry ChallengesA weakening biotech environment through the quarter, with higher cancellations and slower decision-making affecting the company.
Revenue GuidanceThe company posted a book-to-bill ratio lower than expected, leading to a reduction in revenue guidance.
---
Ownership Overview
32.97% Insiders
25.04% Mutual Funds
5.07% Other Institutional Investors
16.81% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MEDP FAQ
What was Medpace Holdings’s price range in the past 12 months?
Medpace Holdings lowest stock price was $253.49 and its highest was $459.77 in the past 12 months.
What is Medpace Holdings’s market cap?
Currently, no data Available
When is Medpace Holdings’s upcoming earnings report date?
Medpace Holdings’s upcoming earnings report date is Feb 17, 2025 which is in 105 days.
How were Medpace Holdings’s earnings last quarter?
Medpace Holdings released its earnings results on Oct 21, 2024. The company reported $3.01 earnings per share for the quarter, beating the consensus estimate of $2.771 by $0.239.
Is Medpace Holdings overvalued?
According to Wall Street analysts Medpace Holdings’s price is currently Undervalued.
Does Medpace Holdings pay dividends?
Medpace Holdings does not currently pay dividends.
What is Medpace Holdings’s EPS estimate?
Medpace Holdings’s EPS estimate is $2.94.
How many shares outstanding does Medpace Holdings have?
Medpace Holdings has 31,081,600 shares outstanding.
What happened to Medpace Holdings’s price movement after its last earnings report?
Medpace Holdings reported an EPS of $3.01 in its last earnings report, beating expectations of $2.771. Following the earnings report the stock price went down -7.475%.
Which hedge fund is a major shareholder of Medpace Holdings?
Among the largest hedge funds holding Medpace Holdings’s share is Spence Asset Management. It holds Medpace Holdings’s shares valued at 157M.
---
Medpace Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$361.17 (14.94% Upside)
$361.17 (14.94% Upside)
Blogger Sentiment
Bullish
MEDP Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 319.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 1.7%
Last 30 Days ▲ 1.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
29.48%
12-Months-Change
Fundamentals
Return on Equity
54.06%
Trailing 12-Months
Asset Growth
40.18%
Trailing 12-Months
Company Description
Medpace Holdings
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.
---
MEDP Company Deck
---
MEDP Earnings Call
Q3 2024
0:00 / 0:00
---
MEDP Revenue Breakdown
31.13% Oncology
19.98% Metabolic
10.27% Cardiology
8.66% AVAI
29.95% Other
---
MEDP Stock 12 Month Forecast
Average Price Target
$361.17
▲(14.94% Upside)
Technical Analysis
Best Analysts Covering MEDP
1 Year
1 Year Success Rate
0/3 ratings generated profit
1 Year Average Return
-12.67%
assigned a buy rating 13 days ago
Copying Charles Rhyee's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -12.67% per trade.
---